Grateful for @curtrward and @StVincentIN leadership in approving the @STVIM Pulmonary and Critical Care Fellowship led by @ejcochard— open and accepting applications for 2 fellows starting July 2023! H/T @gbosslet for support and mentorship in this process!
Happy ERAS opening day! For applicants who did not submit. Do not wait for your letters. Your application is like an Instagram feed. As soon as you post to your "feed", anyone you assigned your application can see it. Good luck! #Match2023
@ElizabethMD15 Ascension St Vincent in Indy is worth a look! Community hospital that is a tertiary care center accepting transfers from around the state so we get a large variety of pathologies! Plenty of tracks including POCUS, global health, and clinical educator @laurelfick@STVIM
it's your lucky 🍀🍀 day!!
#MedTwitter, tune in to hear @Anand_88_Patel work through an exciting new clinical unknown case presented by @RosenelliEM & @SimoneVais!!
Listen here: https://t.co/kjlxD356Vl
Get your day started off with a Global Morning Report case on #HumanDx@hdx by @pearceb317
A 61-year-old male presenting with worsening dyspnea
https://t.co/ROo6po169S
Feeling ~short of breath~ after that Turkey Trot? ~Hot~ after all that cooking?
Then we invite you to listen as @k_vaishnani, @TxID_Edu, & @pearceb317 take on a case of dyspnea and fever!
#Medtwitter, you can listen here: https://t.co/oAODn9rcy6
Hey @CPSolvers Family! Become a Patreon and join us for a Clinical Unknown where I hosted a fantastic episode with some fantastic #ID#InfectiousDisease Educators
Episode 210: Clinical Unknown with @k_vaishnani, @TxID_Edu, and presented by @pearceb317
https://t.co/Lrr0Ob2NWz
Had a blast recording with the @CPSolvers the other day! Thanks for having me @RosenelliEM and thank you showing me how to systemically work through a complex case @TxID_Edu and @k_vaishnani
@MJBurkMD@kidney_boy 🤣 hard to argue with that. Thank you! As @thecurbsiders would say - I’m excited to feed my brain hole with some seriously good knowledge food
Finally caving and getting on Twitter after listening to @kidney_boy ‘s many endorsements of #medtwitter. Let’s see what medical knowledge Twitter has to offer! #IM#critcare#hospitalist
Canagliflozin reduces the risk of kidney failure or death due to cardiovascular or kidney disease by 30% compared to current standard of care.
Read the full CREDENCE trial now published in @NEJM#VisualAbstract
https://t.co/TZOAuZJfpd
@VelezNephHepato@thecurbsiders@kidney_boy@TWhittier_RUSH@DRsonosRD I was originally referring to fluid status assessment in the patients you spoke of in the podcast (AKI in cirrhosis) but I am always willing to learn about POCUS in general if anyone has input about that too!